Our
Clients
Global Parenteral Nutrition Market Analysis by Composition, Consumer, End Use and Region and segments forecast till 2033
Market Overview
The global parenteral nutrition market was worth USD 6,400 million in 2022 and is anticipated to amplify at a CAGR of 6.0% over 2023-2033, thereby accumulating USD 10,700 million by end of the analysis timeline.
The major factors aiding the growth of this marketplace are rising geriatric population, high rate of pre-mature births worldwide, and favorable government initiatives to promote nutritional awareness. Also, increasing prevalence of chronic diseases and metabolic disorders, growing malnutrition across the world, and widespread adoption of home healthcare are positively swaying the market dynamics.
On the contrary, lesser clinical evidence to prove the efficacy of the novel technology and lack of awareness among the masses are likely to impede market progression in the ensuing years. There has been a steep rise in the prevalence of malnutrition particularly in developing and under-developed nation due to lack of food resources and economic disparity. This in turn has increased the demand for parenteral nutrition. Various government and private organizations are taking efforts to develop and provide effective treatment to malnourished individuals, thereby adding traction to the over market expansion.
Rising rate of pre-mature births is creating lucrative opportunities for the market sphere to prosper. Premature babies tend to suffer from underdeveloped immunity and low weight, putting them at a high mortality rate. Therefore, healthcare authorities are focusing on reducing early birth mortalities, thereby aiding market growth.
Report Scope
Report Attributes | Description |
Market Size in 2022 | USD 6,400 Million |
Market Forecast in 2033 | USD 10,700 Million |
CAGR % 2023-2033 | 4.2% |
Base Year | 2022 |
Historic Data | 2020-2021 |
Forecast Period | 2023-2033 |
Report USP | Production, Consumption, company share, company heatmap, company production capacity, growth factors and more |
Segments Covered | Composition, Consumer, and End Use |
Regional Scope | North America, Europe, APAC, South America and Middle East and Africa |
Country Scope | U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Key Companies | Actavis Inc, Fresenius Kabi AG, Pfizer Inc, B. Braun Melsungen AG, Grifolis SA, Baxter International Inc, Otsuka Pharmaceutical Factory Inc, Sichuan Kelun Pharmaceutical Co., Ltd, Vifor Pharma Group, and Allergen, Inc., Amanta Healthcare, Anhui Medipharm Co., Ltd, Aculife Healthcare, Claris Lifesciences Limited, Servona GmbH, ICU Medical, Inc., SGD-Pharma, Groupe Danone, Nutricia North America, Mead Johnson Nutrition Company, Meiji Co., Ltd., Nestl Health Science S.A and Others. |
Impact of COVID
The COVID-19 pandemic has had a significant impact on the Parenteral Nutrition Market, as it disrupted the global healthcare system and supply chains. The lockdowns and restrictions imposed to control the spread of the virus led to a decline in demand for parenteral nutrition products as elective surgeries were postponed and hospital admissions decreased. However, the demand for parenteral nutrition products has started to recover in recent months, driven by an increase in hospital admissions and surgeries. The COVID-19 vaccine rollout and easing of restrictions in some countries have also contributed to the recovery of the market. To aid in the recovery of the Parenteral Nutrition Market, manufacturers and suppliers have been implementing various strategies. These include increasing production capacity to meet the growing demand, ensuring the availability of raw materials and essential components, and implementing cost optimization strategies to maintain profitability.
Companies in the Parenteral Nutrition Market have also been focusing on developing innovative products and expanding their product portfolios to meet the evolving needs of patients and healthcare providers. They are also investing in research and development activities to identify new formulations and delivery systems that can improve patient outcomes and reduce the cost of treatment. Overall, the Parenteral Nutrition Market is expected to continue its recovery in the coming years, driven by an increase in healthcare spending, a growing aging population, and rising incidences of chronic diseases that require parenteral nutrition therapy.
Composition Insights
The composition segment of the parenteral nutrition market refers to the various components used in the formulation of parenteral nutrition solutions. These solutions are primarily made up of carbohydrates, amino acids, lipids, electrolytes, and trace elements. Carbohydrates are the primary source of energy in parenteral nutrition solutions and are usually provided in the form of glucose monohydrate. Amino acids are the building blocks of proteins and are used to support tissue repair and growth. Lipids are a source of essential fatty acids and calories, and they help reduce the risk of liver dysfunction and cholestasis. Electrolytes, such as sodium, potassium, and calcium, are added to parenteral nutrition solutions to maintain electrolyte balance in the body. Trace elements, such as iron, zinc, and copper, are added to prevent micronutrient deficiencies.
Consumer Insights
As parenteral nutrition is administered through an IV or catheter, it is primarily used in hospital settings to treat patients who are unable to consume food orally or through a feeding tube. Therefore, the consumer segment for parenteral nutrition is limited and mainly consists of hospitals and other healthcare facilities. The demand for parenteral nutrition is driven by the number of patients requiring this treatment in hospitals, as well as the availability of healthcare facilities offering this service. However, there is also a growing trend towards home-based parenteral nutrition (HPN) for patients who require long-term PN therapy. This allows patients to receive treatment in the comfort of their own homes and can result in cost savings for healthcare providers. The demand for HPN is expected to increase in the future, driven by factors such as an aging population and the rising incidence of chronic diseases. This may lead to increased demand for parenteral nutrition products by individual consumers or their caregivers.
End Use Insights
The end-use segment of the parenteral nutrition market is mainly divided into hospitals, clinics, and home care settings. Hospitals and clinics are the major end-users of parenteral nutrition products. Hospitals have traditionally been the largest consumers of parenteral nutrition products due to their ability to provide intensive medical care to critically ill patients. Moreover, hospitals have better infrastructure and resources to manage the complex administration and monitoring requirements of parenteral nutrition. However, with the increasing popularity of home parenteral nutrition, the demand from home care settings is expected to witness significant growth in the coming years.
Regional Insights
In terms of geographical ambit, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa are the major benefactors to the growth of this business sphere. Among these, North America captured a market share of 41% in 2021 and is anticipated to showcase similar amplification trends over the forecast period. This is attributable to increasing research expenditure in healthcare sector, rising prevalence of chronic ailments, and favorable reimbursement policies & regulations in the region. Further, Asia Pacific is expected to register substantial CAGR over the stipulated timeline owing to rising chronic disease rate driven by unhealthy eating habits, escalating demand for cost effective treatment, population expansion and low cognizance about nutrition.
Competitive Analysis
Some of the major companies operating within Parenteral Nutrition Market are Actavis Inc, Fresenius Kabi AG, Pfizer Inc, B. Braun Melsungen AG, Grifolis SA, Baxter International Inc, Otsuka Pharmaceutical Factory Inc, Sichuan Kelun Pharmaceutical Co., Ltd, Vifor Pharma Group, and Allergen, Inc., Amanta Healthcare, Anhui Medipharm Co., Ltd, Aculife Healthcare, Claris Lifesciences Limited, Servona GmbH, ICU Medical, Inc., SGD-Pharma, Groupe Danone, Nutricia North America, Mead Johnson Nutrition Company, Meiji Co., Ltd., Nestl Health Science S.A and Others.
Recent News
In June 2021, Baxter International Inc. announced the launch of its new parenteral nutrition formulation, Clinimix E 5/10 in Europe. This product is designed to provide safe and efficient nutrition to patients who are unable to eat or digest food properly.
In March 2021, B. Braun Melsungen AG announced the acquisition of Lauer Membran Wassertechnik GmbH, a company specializing in water treatment systems. This acquisition is expected to help B. Braun expand its portfolio of parenteral nutrition products.
In February 2021, Sichuan Kelun Pharmaceutical Co. Ltd. announced plans to invest approximately USD 53 million to build a new parenteral nutrition production facility in China. The facility is expected to have an annual production capacity of 1,000 tons.
In January 2021, Fresenius Kabi AG announced the launch of its new parenteral nutrition product, Kabiven Peripheral. This product is designed to provide complete and balanced nutrition to critically ill patients who require parenteral nutrition support.
In November 2020, Aculife Healthcare Private Limited announced the launch of its new parenteral nutrition product, Nutriflex Omega Plus, in India. This product is designed to provide essential fatty acids to patients who require parenteral nutrition support.
1. Global Parenteral Nutrition Market Introduction and Market Overview
1.1. Objective of the Market Research Study
1.2. Parenteral Nutrition Market Definition & Description
1.3. Research Data Parameters & Reporting Timelines
1.3.1. Historical Data Reporting Years 2020 to 2021
1.3.2. Projected Data Reporting Years 2022 to 2033
1.3.3. Reporting Data Parameters Value (US$ Million)
1.4. Global Parenteral Nutrition Market Scope and Market Estimation
1.4.1. Global Parenteral Nutrition Overall Market Size (US$ Million), Market CAGR (%), Market Estimates & Forecast (2020 to 2033)
1.4.2. Global Parenteral Nutrition Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2020 to 2033
1.5. Parenteral Nutrition Market Segmentation
1.5.1. Composition of Global Parenteral Nutrition Market
1.5.2. Consumer of Global Parenteral Nutrition Market
1.5.3. End-use of Global Parenteral Nutrition Market
1.5.4. Key Regions of Parenteral Nutrition Market
2. Global Parenteral Nutrition Market - Executive Summary
2.1. Global Parenteral Nutrition Market Summary & Snapshot
2.2. Global Parenteral Nutrition Market, By Composition (US$ Million)
2.3. Global Parenteral Nutrition Market, By Consumer (US$ Million)
2.4. Global Parenteral Nutrition Market, By End-use (US$ Million)
2.5. Global Parenteral Nutrition Market, By Geography (US$ Million)
2.6. Global Parenteral Nutrition Market Outlook & Future Opportunities
3. Parenteral Nutrition Market Trends, Outlook, and Factors Analysis
3.1. Global Parenteral Nutrition Market Industry Development Trends under COVID-19 Outbreak
3.1.1. Global COVID-19 Status Overview
3.1.2. Influence of COVID-19 Outbreak on Global Parenteral Nutrition Market Industry Development
3.1.3. Pre & Post COVID-19 Trends and Scenarios
3.2. Parenteral Nutrition Market Dynamics (Growth Impacting Factors & Rationales)
3.2.1. Drivers
3.2.1.1. The growing burden of various chronic diseases such as diabetes, cancer, and other conditions has led in deficiency in vital and essential nutrients in parents and adults and has created a demand for parenteral nutrition.
3.2.2. Restraints
3.2.2.1. Inappropriate or unsupervised or self-suggested usage of parenteral nutrition can further maximize the risk of patients.
3.2.3. Opportunities
3.2.3.1. Government initiatives made for use and acceptance of parenteral nutrition.
3.2.4. Impact Analysis of Drivers and Restraints
3.3. Ecosystem/ Value Chain Analysis
3.4. Porters Five Forces Analysis
3.5. SWOT Analysis
3.6. PEST Analysis
3.7. Average Selling Prices and Pricing Trends Analysis of Parenteral Nutrition Market
3.8. Technological Roadmap
3.9. Key Investment Pockets of Parenteral Nutrition Market
3.9.1. By Composition
3.9.2. By Consumer
3.9.3. By End-use
3.9.4. By Applications
3.9.5. By Regions
4. Global Parenteral Nutrition Market: Estimates & Historic Trend Analysis (2020 to 2021)
4.1. Global Parenteral Nutrition Market, 2020 2021 (US$ Million)
4.2. Global Parenteral Nutrition Market, By Composition, 2020 To 2021 (US$ Million)
4.3. Global Parenteral Nutrition Market, By Consumer, 2020 To 2021 (US$ Million)
4.4. Global Parenteral Nutrition Market, By End-use, 2020 To 2021 (US$ Million)
4.5. Global Parenteral Nutrition Market, By Region, 2020 To 2021 (US$ Million)
5. Global Parenteral Nutrition Market Estimates & Forecast Trend Analysis, by Composition
5.1. Global Parenteral Nutrition Market Share (%) Estimates and Forecasts, by Composition, 2022 & 2033
5.2. Global Parenteral Nutrition Market Revenue (US$ Million) Estimates and Forecasts, by Composition, 2022 to 2033
5.2.1. Amino Acids
5.2.2. Fats
5.2.3. Carbohydrates
5.2.4. Trace Elements
5.2.5. Vitamins
5.2.6. Minerals
5.2.7. Others
6. Global Parenteral Nutrition Market Estimates & Forecast Trend Analysis, by Consumer
6.1. Global Parenteral Nutrition Market Share (%) Estimates and Forecasts, By Consumer, 2022 & 2033
6.2. Global Parenteral Nutrition Market Revenue (US$ Million) Estimates and Forecasts, by Consumer, 2022 to 2033
6.2.1. Children and Newborns
6.2.2. Adult
7. Global Parenteral Nutrition Market Estimates & Forecast Trend Analysis, by End-use
7.1. Global Parenteral Nutrition Market Share (%) Estimates and Forecasts, By End-use, 2022 & 2033
7.2. Global Parenteral Nutrition Market Revenue (US$ Million) Estimates and Forecasts, by End-use, 2022 to 2033
7.2.1. Hospitals
7.2.2. Clinics
7.2.3. Homecare
7.2.4. Others
8. Global Parenteral Nutrition Market Analysis and Forecast, by Region
8.1. Global Parenteral Nutrition Market Share (%) Estimates and Forecasts, By Region, 2022 & 2033
8.2. Global Parenteral Nutrition Market Revenue (US$ Million) Estimates and Forecasts, By Region, 2022 To 2033
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Middle East and Africa
8.2.5. Latin America
9. North America Parenteral Nutrition Market: Estimates & Forecast Trend Analysis
9.1. North America Parenteral Nutrition Market Assessments & Key Findings
9.2. North America Parenteral Nutrition Market Share (%) Estimates and Forecasts, 2022 & 2033
9.3. North America Parenteral Nutrition Market Size Estimates and Forecast (US$ Million) (2022 To 2033)
9.3.1. By Composition
9.3.2. By Consumer
9.3.3. By End-use
9.3.4. By Major Country
9.3.4.1. The U.S.
9.3.4.2. Canada
10. Europe Parenteral Nutrition Market: Estimates & Forecast Trend Analysis
10.1. Europe Parenteral Nutrition Market Assessments & Key Findings
10.2. Europe Parenteral Nutrition Market Share (%) Estimates and Forecasts, 2022 & 2033
10.3. Europe Parenteral Nutrition Market Size Estimates and Forecast (US$ Million) (2022 to 2033)
10.3.1. By Composition
10.3.2. By Consumer
10.3.3. By End-use
10.3.4. By Major Country
10.3.4.1. Germany
10.3.4.2. The U.K.
10.3.4.3. France
10.3.4.4. Italy
10.3.4.5. Spain
10.3.4.6. Rest of Europe (includes all other European countries)
11. Asia Pacific Parenteral Nutrition Market: Estimates & Forecast Trend Analysis
11.1. Asia Pacific Parenteral Nutrition Market Assessments & Key Findings
11.2. Asia Pacific Parenteral Nutrition Market Share (%) Estimates and Forecasts, 2022 & 2033
11.3. Asia Pacific Parenteral Nutrition Market Size Estimates and Forecast (US$ Million) (2022 To 2033)
11.3.1. By Composition
11.3.2. By Consumer
11.3.3. By End-use
11.3.4. By Major Country
11.3.4.1. China
11.3.4.2. Japan
11.3.4.3. India
11.3.4.4. ASEAN
11.3.4.5. South Korea
11.3.4.6. Rest of Asia Pacific (includes all other Asia Pacific countries)
12. Middle East & Africa Parenteral Nutrition Market: Estimates & Forecast Trend Analysis
12.1. Middle East & Africa Parenteral Nutrition Market Assessments & Key Findings
12.2. Middle East & Africa Parenteral Nutrition Market Share (%) Estimates and Forecasts, 2022 & 2033
12.3. Middle East & Africa Parenteral Nutrition Market Size Estimates and Forecast (US$ Million) (2022 To 2033)
12.3.1. By Composition
12.3.2. By Consumer
12.3.3. By End-use
12.3.4. By Major Country
12.3.4.1. GCC
12.3.4.2. South Africa
12.3.4.3. Egypt
12.3.4.4. Rest of Middle East & Africa (includes all other Middle East & Africa countries)
13. Latin America Parenteral Nutrition Market: Estimates & Forecast Trend Analysis
13.1. Latin America Market Assessments & Key Findings
13.2. Latin America Parenteral Nutrition Market Share (%) Estimates and Forecasts, 2022 & 2033
13.3. Latin America Parenteral Nutrition Market Size Estimates and Forecast (US$ Million) (2022 to 2033)
13.3.1. By Composition
13.3.2. By Consumer
13.3.3. By End-use
13.3.4. By Major Country
13.3.4.1. Brazil
13.3.4.2. Mexico
13.3.4.3. Rest of Latin America (includes all other Latin America countries)
14. Competitive Landscape
14.1. Parenteral Nutrition Market Revenue Share Analysis (%), By Major Players (2021)
14.2. Parenteral Nutrition Market Competition Matrix, By Leading Players
14.3. Parenteral Nutrition List of Emerging, Prominent and Leading Players
14.4. Major Mergers & Acquisitions, Partnership, Joint Venture, Expansions, Deals, Recent Developments, Etc.
15. Company Profiles
15.1. Baxter
15.1.1. Company Overview & Insights
15.1.2. Financial Performance
15.1.3. Product / Service Portfolio
15.1.4. Geographical Footprint & Share
15.1.5. Strategic Initiatives & Key Developments
*Similar details would be provided for all the players mentioned below
15.2. Baxter
15.3. Allergan
15.4. Actavis Inc
15.5. Otsuka Pharmaceutical Factory, Inc
15.6. Grifols, S.A.
15.7. B. Braun Melsungen AG
15.8. Vifor Pharma
15.9. Fresenius Kabi AG
15.10. Sichuan Kelun Pharmaceutical Co., Ltd.
15.11. Pfizer Inc
15.12. Amanta Healthcare
15.13. Anhui Medipharm Co., Ltd
15.14. Aculife Healthcare
15.15. Claris Lifesciences Limited
15.16. Servona GmbH
15.17. ICU Medical, Inc.,
15.18. SGD-Pharma
15.19. Groupe Danone
15.20. Nutricia North America
15.21. Mead Johnson Nutrition Company
15.22. Meiji Co., Ltd.
15.23. Nestl Health Science S.A
15.24. Others
16. Assumptions and Research Methodology
16.1. Data Mining
16.2. Secondary Research
16.3. Primary Research
16.4. Subject Matter Expert Advice
16.5. Quality Check
16.6. Final Review
16.7. Data Triangulation
16.8. Bottom-Up Approach
16.9. Top Down Approach
16.10. Research Flow
16.11. Key Insights from Industry Experts
16.12. Data Compositions
16.13. Assumptions
16.14. Limitations
17. Conclusions and Recommendations
17.1. Key Research Findings and Conclusion
17.2. Key Insights & Recommendations from Analysts
